HAMBURG, Germany, Sept. 16, 2008 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (Nasdaq:EVTC) announced today that the Company participates via convertible bonds in the sale of Direvo Biotech AG to Bayer HealthCare AG published this morning. Evotec holds convertible bonds valued at approximately EUR 5 million which Evotec received as part of the compensation for the sale of its equity holding in Direvo in May 2007.
